Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness Analysis

Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy

(2013) Rohit Loomba et al.   ANNALS OF INTERNAL MEDICINE

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening for hepatitis B surface antigen before chemotherapy: current practice and opportunities for improvement

(2011) R. Lee et al.   Current Oncology

Cost-Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Solid Tumors

(2011) Fiona L. Day et al.   JOURNAL OF CLINICAL ONCOLOGY

Cost effectiveness of screening immigrants for hepatitis B

(2011) William W. L. Wong et al.   LIVER INTERNATIONAL

Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades

(2011) László Tabár et al.   RADIOLOGY

The cost-effectiveness of screening for colorectal cancer

(2010) J. J. Telford et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases

(2010) Andrew S. Artz et al.   JOURNAL OF CLINICAL ONCOLOGY

Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer

(2010) P. A. Bradbury et al.   JNCI-Journal of the National Cancer Institute

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

(2009) Sung-Nan Pei et al.   ANNALS OF HEMATOLOGY

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

Cost Trajectories at the End of Life: The Canadian Experience

(2009) Konrad Fassbender et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

(2008) Yi-Fu He et al.   ANNALS OF HEMATOLOGY

Oncologists and Hepatitis B: A Survey to Determine Current Level of Awareness and Practice of Antiviral Prophylaxis to Prevent Reactivation

(2008) Omar S. Khokhar et al.   CHEMOTHERAPY

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

(2008) Winnie Yeo et al.   JOURNAL OF CLINICAL ONCOLOGY